Managing Recurrent Pericarditis
Heart Podcast
00:00
Exploring Rylonasept for Recurrent Pericarditis
This chapter dives into the medication Rylonasept, a cytokine trap targeting IL-1 alpha and beta, and its benefits for patients with recurrent pericarditis. It discusses the design and results of the Rhapsody trial, detailing symptom improvements and reduced recurrence rates. The chapter also covers a staged therapy withdrawal trial and plans for a long-term registry study on pericarditis.
Transcript
Play full episode
